Investment & Partnering
Investor Information
Axial Biotech is a privately held company pioneering the development of novel DNA-based prognostic testing products that have the potential to revolutionize the practice of orthopedics.
Since the founding of the company 6 years ago, Axial has largely focused on the development of a DNA-based prognostic test for Adolescent Idiopathic Scoliosis, the market for which is estimated by Axial to be in excess of $200 million annually. However, this is only the beginning of the change we intend to bring to spine care. We have already begun the development of new projects aimed at the most widespread spinal disorders. Our discoveries about the genetic nature of spine disorders may one day allow the combination of individual prognostic test results with motion-preserving implants and molecular therapeutics for truly personalized care resulting in the best outcome for every patient.
Over the next several years, we will launch product development programs for:
DNA-based diagnostics/prognostics for other spinal disorders (Degenerative Disc Disease, Spondylolisthesis, Scheuermann’s Disease, Osteoarthritis and Osteoporosis)
For information regarding investment opportunities please contact:
John M. Climaco
President / CEO
jclimaco@classicmodelsagency.com
Partnering Information
Axial Biotech understands what it takes to develop and deliver treatments and diagnostics to patients.
We seek strategic collaborations to expand our commercialized products and services, to supplement our product pipeline, and to access complementary research, technology and development capabilities.
We combine our strengths with others and work collaboratively with partners to develop and commercialize therapeutic products and diagnostic services.
We have a proven track record of moving products from research through to commercialization. Our capabilities include world-class science, as well as experienced product development, medical, clinical and regulatory, marketing, sales and reimbursement expertise.
For information regarding investment or partnership opportunities please contact:
Joe Ross
Vice President
Strategic Initiatives
jross@classicmodelsagency.com
